Mini

Developing functional pancreatic cells

Cristina Nostro, senior scientist at McEwen Stem Cell Institute, UHN, is a pioneer in developing insulin-producing cells as a cell therapy. She collaborates with UHN’s Sara Nunes Vasconcelos, a senior scientist who’s a vasculature, or blood vessel, expert. Together, they are developing a cell therapy for type 1 diabetes. Read more.

By |2023-06-07T16:41:11-04:00May 30th, 2023|Categories: 5 ways diabetes, Mini|

Cloaking insulin-producing cells to evade the immune system

A team led by Andras Nagy, senior investigator at Sinai Health System, has been developing a method called cloaking to enable treatments for type 1 diabetes. The cloaking technology turns off certain genetic switches in the cells to avoid detection and rejection by the immune system. Read more.

By |2023-06-07T16:42:27-04:00May 30th, 2023|Categories: 5 ways diabetes, Mini|

Engineering the immune system to accept insulin-producing cells

A team led by Sunnybrook Research Institute’s Juan Carlos Zúñiga-Pflücker, is working on immune-engineering techniques to enable a treatment for type 1 diabetes. The team’s strategy is to finely tune the immune system to maintain a healthy system while not rejecting a therapeutic transplant. Read more.

By |2023-06-13T07:57:24-04:00May 30th, 2023|Categories: 5 ways diabetes, Mini|
Go to Top